Trials / Completed
CompletedNCT01774019
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients With Resectable Pancreatic or Periampullary Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 284 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that preoperative biliary drainage using self-expanding metal stents (SEMS) does not negatively impact overall surgical outcomes in patients undergoing pancreaticoduodenectomy for treatment of pancreatic or periampullary cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WallFlex™ Biliary RX Fully Covered/Uncovered Stent System |
Timeline
- Start date
- 2013-02-20
- Primary completion
- 2021-12-13
- Completion
- 2021-12-13
- First posted
- 2013-01-23
- Last updated
- 2023-04-10
- Results posted
- 2023-04-10
Locations
11 sites across 9 countries: United States, Australia, Belgium, China, France, Hong Kong, India, Italy, Japan
Source: ClinicalTrials.gov record NCT01774019. Inclusion in this directory is not an endorsement.